# Clinical Applications of Bovine Colostrum in GastrointestinaI Disorders: Mechanisms, Evidence, and Therapeutic Potential

**Authors:** Yusuf Serhat Karakülah, Yalçın Mert Yalçıntaş, Mikhael Bechelany, Sercan Karav

PMC · DOI: 10.3390/ijms262110673 · International Journal of Molecular Sciences · 2025-11-01

## TL;DR

Bovine colostrum shows promise as a natural treatment for gastrointestinal disorders due to its bioactive components that support gut health and reduce inflammation.

## Contribution

This review provides a mechanistic explanation of bovine colostrum's effects and highlights its potential for clinical translation in GI disorders.

## Key findings

- Bovine colostrum components like IgG and lactoferrin help repair epithelial tissue and reduce inflammation.
- Studies show it improves intestinal permeability and reduces markers of inflammation in conditions like IBD and IBS.
- Bovine colostrum formulations are being studied for oral and enteral administration with promising tolerability and efficacy.

## Abstract

Bovine colostrum stands out as a natural supplement with rich bioactive components that attract attention for its therapeutic potential in the maintenance and improvement of gastrointestinal (GI) health. The major bioactive components of bovine colostrum include immunoglobulin (Ig) (especially immunoglobulin G), lactoferrin (LF), growth Factors (IGF-I, TGF-β, EGF), oligosaccharides (OS), and bioactive peptides. These components play a role in epithelial repair, suppression of inflammation, balancing the microbiota, and enhancing the mucosal barrier. Various animal models and recent human studies show that bovine colostrum has various positive effects against gastrointestinal tract diseases such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), non-steroidal anti-Inflammatory drug (NSAID)-induced enteropathy, and necrotizing enterocolitis (NEC). These effects include preservation of epithelial integrity, reduction of inflammatory markers, and improvement of intestinal permeability. Studies on the tolerability and efficacy profiles of various bovine colostrum formulations for oral, oropharyngeal, and enteral administration are increasing. In this review, the multifaceted effects of bovine colostrum on the gastrointestinal tract are explained at a mechanistic level, and potential areas of study for clinical translation are presented. Bovine Colostrum stands out as a promising natural biotherapeutic agent for both preventive and therapeutic approaches.

## Linked entities

- **Proteins:** tf.S (transferrin S homeolog), IGF1 (insulin like growth factor 1), TGFB1 (transforming growth factor beta 1), EGF (epidermal growth factor)
- **Diseases:** inflammatory bowel disease (MONDO:0005265), irritable bowel syndrome (MONDO:0005052), necrotizing enterocolitis (MONDO:0004639)
- **Species:** Bos taurus (taxon 9913)

## Full-text entities

- **Genes:** LTF (lactotransferrin) [NCBI Gene 280846] {aka Lf}, IGFI (Insulin-like growth factor 1 level) [NCBI Gene 104978413], EGF (epidermal growth factor) [NCBI Gene 530315]
- **Diseases:** NEC (MESH:D020345), IBD (MESH:D015212), inflammation (MESH:D007249), GastrointestinaI Disorders (MESH:D009358), IBS (MESH:D043183), enteropathy (MESH:C538273), gastrointestinal tract diseases (MESH:D005770)
- **Chemicals:** OS (MESH:D009844)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12608013/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12608013/full.md

## References

124 references — full list in the complete paper: https://tomesphere.com/paper/PMC12608013/full.md

---
Source: https://tomesphere.com/paper/PMC12608013